EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

P53 expression in marrow biopsies from patients with hypercellular refractory anemia, hypocellular refractory anemia and aplastic anemia



P53 expression in marrow biopsies from patients with hypercellular refractory anemia, hypocellular refractory anemia and aplastic anemia



Laboratory Investigation 76(1): 135A




(PDF emailed within 1 workday: $29.90)

Accession: 032694450

Download citation: RISBibTeXText



Related references

Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia. Annals of Hematology 77(6): 261-264, 1999

Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: Aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia. Annals of Hematology 77(6): 261-264, 1998

Pattern of p53 expression in bone marrow biopsies from patients with bone marrow failure Fanconis anemia, hypocellular refractory anemia and acquired aplastic anemia. Blood 90(10 SUPPL 1 PART 2): 12B-13B, Nov 15, 1997

P53 overexpression in bone marrow biopsies in refractory anemia and aplastic anemia: Impact of antibody selection. Leukemia Research 24(11): 975-977, November, 2000

F-blast is a useful marker for differentiating hypocellular refractory anemia from aplastic anemia. International Journal of Hematology 75(3): 257-260, April, 2002

Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis. Haematologica 82(1): 21-24, 1997

Effects of epoetin beta given in combination with granulocyte colony-stimulating factor on the anemia of patients with aplastic anemia and refractory anemia. Blood 88(10 SUPPL 1 PART 1-2): 348A, 1996

Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia. Pathology International 58(6): 353-360, 2008

A case of hypoplastic acute leukemia which transformed naturally from hypercellular bone marrow to hypocellular with reference to the atypical aplastic anemia. Japanese Journal of Clinical Hematology 22(11): 1743-1750, 1981

Factors influencing nonleukemic death in refractory anemia, refractory anemia with ring sideroblasts, and refractory anemia with excess of blasts. Cancer Research 47(13): 3599-3602, 1987

Aplastic Anemia and Refractory Anemia with the HLA-DR15 Haplotype A Bone Marrow Failure Syndrome Caused by Common Immune-Mechanisms. Blood 100(11): Abstract No 877, November 16, 2002

Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia. Leukemia Research 24(4): 359-366, April, 2000

Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia. Hematologic Pathology 7(3): 153-158, 1993

Clinically relevant possibilities and limits of differential diagnosis of megaloblastic anemia and myelodysplastic syndrome - refractory anemia type in bone marrow biopsies. Vnitrni Lekarstvi 62(9): 692-697, 2016

Refractory anemia with hypercellular bone marrow and preleukemia. Medizinische Klinik 71(48): 2127-2135, 1976